Palladia (Toceranib Phosphate) for Dogs, 10 mg (Blue), Mast Cell Tumor Treatment for Dogs
Product details
| Management number | 252258840 | Release Date | 2026/10/01 | List Price | $105.77 | Model Number | 252258840 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
Palladia (toceranib phosphate) tablets is an FDA-approved treatment for canine mast cell tumors. It is indicated for Patnaik grades 2 or 3, concurrent, cutaneous mast cell tumors with or without regional lymph node involvement in dogs. Palladia combines antiangiogenic and antiproliferative properties to kill these tumors by cutting off their blood supply and inhibiting the production of cancerous cells. It’s available by prescription only. Follow your veterinarian’s instructions as prescribed.
- At-Home Mast Cell Tumor Treatment for Dogs: Prescription oral tablets used to treat certain types of mast cell tumors, a common form of cancer in dogs
- Works in Two Ways: Combines antiangiogenic and antiproliferative effects to kill tumor cells and cut off blood supply to the tumor.
- Effective: 37% of dogs showed an objective decrease in mast cell tumor size in a study.¹
- Administered Orally: Can be given with or without food, according to your veterinarian instructions.
| Animal type | Dog |
|---|---|
| Medicine strength | 10mg |
| Animal health concern | Cancer, Tumors |
| Brand | Palladia |
| Pharmacy product status | Active |
| Medicine form | Oral |
| Enteral medication form | Tablets |
| Pharmacy product category | Branded RX |
| Retail packaging | Single Piece |
| Piece count | 30 |
| Multipack quantity | 30 |
| Pieces | 30 |
| Fda approved for animals | Y |
| Animal breed | Dog |
| Is intended for human consumption | N |
| Product net content parent | 30 Each |
| Product net content uom | Each |
| Dea class | None/NC (Not Controlled) |
Bestseller ranking
Pet Loss
Customers who viewed this product also viewed
Dog Medication
Correction of product information
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form